Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ion Pacific is a financial organization founded in 2015 by Itamar Har-Even and Michael Joseph. The firm operates across multiple locations in the US, Europe, and Asia, focusing on structured investments in secondary opportunities within the venture-stage technology sector. This approach aims to provide better return-risk potential than traditional venture capital.
The organization specializes in sophisticated financing structures designed to assist general partners (GPs), limited partners (LPs), and founders in meeting liquidity needs. Investors benefit from future asset upside, making Ion Pacific a unique player in the venture capital space.
Ion Pacific manages several funds, including Stonecutter, Pathway, and Southeast Asia Opportunities, reflecting its commitment to structured secondaries across diverse sectors. The firm has grown since its inception, establishing a strong presence in the global investment landscape.
Ion Pacific invests in venture-stage companies through a structured secondaries approach, which combines downside protection with uncapped upside return potential. This investment strategy spans various sectors, including healthcare, biotech, and fintech, with a global focus across North America, Europe, and Asia.
The organization manages multiple funds, such as Stonecutter, a venture capital structured secondaries fund currently on its third vintage since its inception in 2018. The Pathway fund, launched in 2021, focuses on life sciences, applying the structured secondaries approach to healthcare and med-tech investments. Additionally, the Southeast Asia Opportunities fund, initiated in 2022, targets VC investments specifically in Southeast Asia.
Ion Pacific seeks to provide innovative financing solutions that enhance liquidity while maintaining growth potential for startups and VCs. Their structured secondaries investment approach is designed to meet the needs of GPs, LPs, and founders, allowing them to navigate the complexities of venture capital financing.
Ion Pacific's portfolio includes a variety of venture-stage companies, although specific names and descriptions of notable portfolio companies were not provided. The firm focuses on sectors such as healthcare, biotech, and fintech, aligning with its investment strategy in structured secondaries.
While the exact details of the portfolio companies remain undisclosed, the emphasis on structured secondaries indicates a diverse range of investments that benefit from the firm's unique approach to financing. This strategy allows Ion Pacific to engage with companies that have significant growth potential while providing liquidity solutions.
Itamar Har-Even: Co-CEO, Managing Partner, and Investment Committee Member. He has extensive experience in venture capital and structured investments.
Michael Joseph: Co-CEO, Managing Partner, and Investment Committee Member. He brings a wealth of knowledge in financial structuring and investment strategies.
Ady Adefris: Managing Director and Chief Operating Officer, responsible for operational management and strategic initiatives.
Kristaps Ronis: Partner with expertise in venture capital investments and portfolio management.
Kevin Henderson: Partner focusing on structured financing and investment strategies.
Najeh Albustami: Partner with a background in venture capital and investment analysis.
Jonathan Chia: Associate involved in deal sourcing and analysis.
Katie Young: Analyst contributing to research and portfolio management.
Fabio Furlani: Analyst focused on market analysis and investment opportunities.
Henry Fung: Analyst supporting investment research and portfolio evaluation.
Daniele Brocca: Analyst assisting in deal analysis and due diligence.
To pitch to Ion Pacific, founders should send their proposals to info@ionpacific.com. A well-structured pitch deck is essential, including details on the business model, market analysis, and financial forecasts.
While there is no specific application form, a concise and compelling presentation is crucial. Response times may vary, but founders can expect to hear back within a few weeks.
In 2021, Ion Pacific launched the Pathway fund, focusing on life sciences and applying their structured secondaries approach to healthcare and med-tech investments.
In 2022, the firm initiated the Southeast Asia Opportunities fund, targeting VC investments specifically in Southeast Asia, reflecting their commitment to expanding their investment footprint.
Ion Pacific continues to manage the Stonecutter fund, which is currently on its third vintage since its inception in 2018, showcasing their ongoing activity in structured secondaries.
What are Ion Pacific's investment criteria?
Ion Pacific focuses on venture-stage companies in healthcare, biotech, and fintech sectors. They employ a structured secondaries approach, which combines downside protection with uncapped upside potential.
How can I apply or pitch to Ion Pacific?
Founders can pitch their ideas by contacting Ion Pacific at info@ionpacific.com. A detailed pitch deck outlining the business model, market opportunity, and financial projections is recommended.
What makes Ion Pacific different from other venture capital firms?
Ion Pacific specializes in structured secondaries investments, providing a unique approach that enhances liquidity for GPs, LPs, and founders while maximizing growth potential for investors.
What is Ion Pacific's geographic scope?
The firm operates globally, with a focus on North America, Europe, and Asia, allowing them to tap into diverse markets and investment opportunities.
What is the typical fund size or check size for investments?
While specific fund sizes are not disclosed, Ion Pacific manages multiple funds, including Stonecutter, Pathway, and Southeast Asia Opportunities, indicating a significant capital base for investments.
What is Ion Pacific's involvement post-investment?
Ion Pacific provides support to portfolio companies through structured financing solutions, helping them navigate liquidity challenges while aiming for future asset appreciation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.